Abbott's New Spinal Cord Stimulation Device Receives the US FDA’s Approval for Chronic Pain
Shots:
- The US FDA has approved Abbott's Proclaim Plus SCS system to deliver FlexBurst360 therapy & superior pain relief along with adding more treatment options for evolving pain conditions
- Abbot's FlexBurst360 therapy & Burst DR stimulation that works by mimicking natural patterns in the brain, provides pain relief in ~6 different locations of the trunk or limbs, allowing programming that may be changed as a person's therapeutic needs
- Proclaim Plus has a recharge-free battery lasting up to 10yrs. and can be used with the NeuroSphere virtual clinic which facilitates secure in-app video chat with a physician, ensure proper functionality & remote adjustments to their therapeutic settings as needed
Ref: PRNewswire | Image: Abbott
Click here to read the full press release
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
